MEASURE

TRACK

DISSEMINATE

The purpose of the HCV Dashboard is to measure, track and disseminate actionable information on progress towards eliminating hepatitis C as a public health problem in New York State.

 ABOUT THE HCV DASHBOARD  

Hepatitis C (HCV) is a major public health problem causing substantial illness and death, including cirrhosis and liver cancer. Nationally, three out of four people living with HCV are persons born between 1945 and 1965, but most new infections occur because of injection drug use. Many people with HCV are unaware they are infected. Yet, current highly effective direct-acting antiviral therapies can cure this disease with minimal side effects, making it possible to eliminate HCV.

In November 2021, New York State (NYS) released its HCV Elimination Plan, which provides recommendations that will lead NYS towards eliminating hepatitis C as a public health problem. Recommendations include five areas of focus: Prevention, Testing and Linkage to Care, Care and Treatment Access, Social Determinants of Health, and Surveillance, Data, and Metrics.

Plan recommendations include the creation of a dashboard system to track and disseminate timely statewide, regional or county-level information on key HCV elimination outcomes to the initiative’s stakeholders, including people infected and affected by HCV, to convey progress towards achieving the goals and targets of the initiative.

By making state and local HCV data available to all stakeholders, the HCV Dashboard will track New York State’s progress towards HCV elimination.
Learn more

 HCV ELIMINATION TARGETS  

INCREASE
DIAGNOSES

90% of people living with HCV will be diagnosed

INCREASE
TREATMENT

80% of people diagnosed with HCV will be treated or will have cleared infection

REDUCE NEW
INFECTIONS

80% reduction in new HCV infections

REDUCE
PREVALENCE

90% reduction in people living with HCV

DECREASE
DEATHS

65% reduction in liver related deaths

READ MORE ABOUT HCV TARGETS AND METRICS

 HCV IN NEW YORK STATE  

Newly Reported Hepatitis C • Case rate per 100,000 pop.
• NYS (excl. NYC) • 2012-2019
Data not shown
Explore Data

  WHAT’S NEW  

@HCVDashboardNY on Twitter

NYSDOH_CEIClinical Education Initiative@NYSDOH_CEI·
8 Sep

A panel of experts will be speaking about #HCV in NYS on day 2 of the 2022 NYS Hepatitis C and Drug User Health conference! Join us for this session at 10:00am on September 22nd. #HCVElimination @AnnetteGaudino @HealthNYGov @HCVDashboardNY Register here: https://bit.ly/HCVDUH2022

Reply on Twitter 1567924512351555587Retweet on Twitter 15679245123515555873Like on Twitter 15679245123515555874Twitter 1567924512351555587
HCVDashboardNYHCVDashboardNY@HCVDashboardNY·
18 Jul

The New York State Hepatitis C (HCV) Learning Collaborative aims to build capacity for HCV testing and linkage to care among substance use disorder treatment programs. Read more in our recent blog: http://hcvdashboardny.org/nys-hcv-learning-collaborative-launched/

Reply on Twitter 1549046480732065792Retweet on Twitter 1549046480732065792Like on Twitter 15490464807320657921Twitter 1549046480732065792
View more tweets